Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats - Test2 - elhamkhani - TriplyDB

Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats

Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats

http://www.wikidata.org/entity/Q28546739

about

Preparation of the Potential Ocular Inserts by Electrospinning Method to Achieve the Prolong Release Profile of Triamcinolone Acetonide.

P2860

Q55057019-773584AD-FB44-4A63-B7E2-F90FB13A02DB

P2860

Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats

http://www.wikidata.org/entity/Q28546739

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@ast

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@en

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@nl

type

label

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@ast

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@en

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@nl

prefLabel

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@ast

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@en

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@nl

P1433

Q28546739-C3E44D8D-4184-498B-A801-0E9D6E320FCC

P1476

Q28546739-044283C9-1836-4533-B8D7-EC578BC3CCE4

P2093

Q28546739-0C9F4C9E-4326-415A-8AA6-B1EFEBE475BC

Q28546739-1E85C866-5CEE-434F-A3B2-8F641546EC44

Q28546739-28F07FF8-CACB-466B-A6A7-1CB5D20AE08C

Q28546739-3498DB21-CD8C-4C09-AB2A-EF8510464EF6

Q28546739-3673A2D5-49C8-406D-B309-AFDF6634BDE6

Q28546739-42AD35B3-B83F-49A0-8B05-67DAC0AA463C

Q28546739-7D2C8924-80E3-4892-9DAD-84B93BD8FD69

Q28546739-8AB8E9E2-4E09-4FE0-B38A-37F331C1E743

Q28546739-8AE9534C-45FB-4D9F-8DE3-CD3FD46C5BBA

Q28546739-ADDCB334-DE72-4C8C-B033-E93192D85CEC

P2860

Q28546739-08AFDC5F-E80E-4968-A7B8-7AD2316690A0

Q28546739-0912053D-3595-44D8-97D2-1C95AC2793DB

Q28546739-17E50034-8096-4F2B-8105-589B6D19E740

Q28546739-1ECC23BA-94AD-4FB3-8BD3-342CE226164D

Q28546739-25D13BE5-599C-449E-9420-82885ED674FB

Q28546739-28766B39-7E20-4F98-B4A8-F8CA795CAAA6

Q28546739-2B6E6DF9-FEDA-4FFC-9FF1-1F41E645054E

Q28546739-2B8B1E5B-C6A6-4FEC-916B-9C248C69B9BC

Q28546739-3337BB04-3557-47BC-ABFA-31A873286BAA

Q28546739-35259743-C44F-4391-9327-4E8C0C65D3B0

P304

Q28546739-85CB6300-194C-4D49-9564-DFE7F49C7999

P31

Q28546739-F195F910-31DF-4A76-8810-E91EE9196978

P356

Q28546739-F82E0701-2503-4FD5-AAD1-FEDAF2CD1D09

P407

Q28546739-7ED66404-E7BD-437E-ADF1-00FDF25C2E04

P433

Q28546739-80ED96AC-5098-4134-8D14-BDA20E5DF5D7

P478

Q28546739-E6F8985E-6FB5-438D-A0D8-4345302DEFCF

P50

Q28546739-644E7A7C-C812-4F6B-978E-2CC100526466

P577

Q28546739-EF59EF9A-B075-462A-8B37-00EEF838A3F9

P5875

Q28546739-2679928E-0980-4145-B0BB-CE45DE1024EC

P698

Q28546739-864AD1D3-5BC3-4A29-814C-406932225479

P932

Q28546739-CB723C45-31DA-4D80-BF5B-48071B7D9913

P356

JOURNAL.PONE.0133149

P1433

P1476

Ocular Inserts for Sustained R ...... ate, to Treat Glaucoma in Rats

@en

P2093

Anderson José Ferreira

http://www.w3.org/2001/XMLSchema#string

André Augusto Gomes Faraco

http://www.w3.org/2001/XMLSchema#string

Giselle Foureaux

http://www.w3.org/2001/XMLSchema#string

Gustavo de Oliveira Fulgêncio

http://www.w3.org/2001/XMLSchema#string

José Carlos Nogueira

http://www.w3.org/2001/XMLSchema#string

Juçara Ribeiro Franca

http://www.w3.org/2001/XMLSchema#string

Maria Irene Yoshida

http://www.w3.org/2001/XMLSchema#string

Rachel Oliveira Castilho

http://www.w3.org/2001/XMLSchema#string

Sebastião Cronemberger

http://www.w3.org/2001/XMLSchema#string

Simone Odília Antunes Fernandes

http://www.w3.org/2001/XMLSchema#string

P2860

The number of people with glaucoma worldwide in 2010 and 2020

Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction

Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes.

A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization.

Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.

Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.

Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice

Prediction of off-target effects on angiotensin-converting enzyme 2.

Angiotensin-(1-7): an update.

Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.

P304

e0133149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0133149

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Leonardo Lima Fuscaldi

P577

2015-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280491160

http://www.w3.org/2001/XMLSchema#string

P698

26204514

http://www.w3.org/2001/XMLSchema#string

P932

4512709

http://www.w3.org/2001/XMLSchema#string